Vertex Pharmaceuticals Incorporated
Research & Development
11010 Torreyana Road
San Diego
California
92121
United States
Tel: 858-404-6600
Fax: 858-404-6726
Website: http://www.vrtx.com/
About Vertex Pharmaceuticals Incorporated
179 articles about Vertex Pharmaceuticals Incorporated
-
GlobalDataWith the Threat of Competition Looming, Vertex Pharmaceuticals (MA) Boasts of Promising New HCV Therapy
8/2/2012
-
Vertex Pharmaceuticals (CA): Phase 3 STRIVE Study of VX-770 Showed Durable Improvements in Lung Function (FEV1) and Other Measures of Disease Among People With a Specific Type of Cystic Fibrosis
6/10/2011
-
Vertex Pharmaceuticals (CA) Plans to Provide Access to Potential CF Therapy VX-770 for Patients with Critical Medical Need
6/10/2011
-
Vertex Pharmaceuticals (CA) Announces Webcasts of its Presentations at Two Investor Conferences
5/27/2011
-
Vertex Pharmaceuticals (CA) Announces Webcasts of its Presentations at Two Investor Conferences
5/2/2011
-
Vertex Pharmaceuticals (CA) Stock Trading Halted Amid FDA Review
4/28/2011
-
Vertex Pharmaceuticals (CA) Rises After FDA Staff Says Hepatitis C Drug Is Effective
4/26/2011
-
Vertex Pharmaceuticals (CA) Announces the Date of its Full Year 2010 Financial Results Conference Call and Webcast
1/24/2011
-
Vertex Pharmaceuticals (CA) Announces Key Business Objectives To Support Planned Launch of Telaprevir in Hepatitis C and Continued Progress in Other Serious Diseases
1/10/2011
-
Vertex Pharmaceuticals (CA) Announces Webcast of its Presentation at the 29th Annual J.P. Morgan Healthcare Conference
1/6/2011
-
Vertex Pharmaceuticals (CA) Ends Part Of Telaprevir Phase II Study For Hepatitis C
12/22/2010
-
"Warehoused" Hepatitis C Patients May Boost Merck & Co., Inc., Johnson & Johnson, Vertex Pharmaceuticals (CA)
4/19/2010
-
Vertex Pharmaceuticals (CA) Announces the Date of its First Quarter 2010 Financial Results Conference Call and Webcast
4/6/2010
-
Vertex Pharmaceuticals (CA) Reviews 2010 Business Priorities to Support Goal of Becoming Fully-Capable Biopharmaceutical Company
1/11/2010
-
Bend Research and Vertex Pharmaceuticals (CA) Enter New Scientific Collaboration Bend to Provide Novel Formulation Development and Manufacturing Services for Specific Vertex-led Projects and Clinical Trials
11/9/2009
-
Vertex Pharmaceuticals Incorporated Provides Corporate Update
10/1/2009
-
Vertex Pharmaceuticals (CA) (JOBS) to Receive $155 Million in Cash Related to Future Telaprevir Milestone Payments
10/1/2009
-
Vertex Pharmaceuticals Incorporated Announces Publication of Telaprevir Abstracts for Presentation at the 60th AASLD Meeting
9/24/2009
-
Vertex Pharmaceuticals Incorporated Employees Participate in First Companywide Day of Service
9/22/2009
-
Vertex Pharmaceuticals Incorporated Announces Webcast of its Presentations at Two Investor Conferences
9/18/2009